4//SEC Filing
Klimovsky Judith V 4
Accession 0001628280-22-000411
CIK 0001358403other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 9:34 AM ET
Size
10.4 KB
Accession
0001628280-22-000411
Insider Transaction Report
Form 4
Klimovsky Judith V.
Director
Transactions
- Exercise/Conversion
Common Stock
2022-01-04+14,036→ 14,036 total - Exercise/Conversion
Common Stock
2022-01-04+566→ 14,602 total - Exercise/Conversion
Restricted Stock Units
2022-01-04−14,036→ 0 total→ Common Stock (14,036 underlying) - Exercise/Conversion
Restricted Stock Units
2022-01-04−566→ 0 total→ Common Stock (566 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of BLCM common stock.
- [F2]The RSUs vest in full upon the one year anniversary of the grant date on January 4, 2021.
- [F3]The RSUs granted on July 1, 2021 vest in full on January 4, 2022.
Documents
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeother
Related Parties
1- filerCIK 0001762247
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 9:34 AM ET
- Size
- 10.4 KB